Atrial fibrillation fact sheet in Korea 2024:part 2—stroke prevention in Korean patients with atrial fibrillation
10.1186/s42444-024-00120-x
- Author:
Pil‑sung YANG
1
;
Ju Youn KIM
;
Bong‑Seong KIM
;
Kyung‑Do HAN
;
Junbeom PARK
;
Min Soo CHO
;
Jung Myung LEE
;
Jong Sung PARK
;
Ki Hong LEE
Author Information
1. Division of Cardiology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea
- Publication Type:RESEARCH
- From:International Journal of Arrhythmia
2024;25(3):14-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:Atrial fibrillation (AF) increases the risk of thromboembolic events, making oral anticoagulants (OACs) essential for high-risk patients. This fact sheet provides nationwide statistics on AF management for stroke prevention in Korea. We aimed to evaluate current anticoagulation treatment trends and strategies in Korea.MethodThe Korean national health claims database from the National Health Insurance Service was used. AF patients aged ≥ 18 years from 2013 to 2022 were included. OAC use, including warfarin and non-vitamin K antagonist OACs (NOACs), was tracked through prescription data. The rates of OAC use were calculated based on continued use, considering prescription dates and amounts. For patients with multiple encounters, the last encounter was used for analysis.
Results:During the study, 20.4% of strokes were accompanied by AF, with AF diagnosed within 6 months before or after the stroke. The number of patients diagnosed with AF after a stroke increased from 4893 in 2013 to 6978 in 2022. Among newly diagnosed AF patients requiring OACs, 51% were not prescribed OACs within 6 months. OAC treatment rates for high-risk AF patients increased from 44.6% in 2013 to 77.5% in 2022, with NOAC prescriptions rising significantly after 2015. Regional variations in OAC prescription rates were observed, with lower rates in suburban/rural areas than in urban regions (76.0% vs. 79.6%, p < 0.001).
Conclusions:Considerable strokes could have been prevented with earlier AF detection and OAC treatment through more intensive electrocardiogram screening.
